SCHEMBL4959609

SCHEMBL4959609

O=C(Nc1nc2c(s1)Cc1ccccc1-2)c1cccnc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.71
KMT2A Q03164 8/20 0.71
MEN1 O00255 7/20 0.71
ALDH1A1 P00352 6/20 0.71
BLM P54132 2/20 0.71
L3MBTL1 Q9Y468 1/20 0.71
NPC1 O15118 6/20 0.58
RAB9A P51151 6/20 0.58
ADORA1 P30542 3/20 0.58
ADORA2A P29274 2/20 0.58
LMNA P02545 5/20 0.57
KDM4E B2RXH2 3/20 0.57
POLB P06746 2/20 0.57
APAF1 O14727 2/20 0.57
HPGD P15428 1/20 0.57
SCD O00767 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.53
TP53 P04637 3/20 0.51
TDP2 O95551 1/20 0.51
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1822988 0.88 MAPT (0.70) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4960241 0.87 ADORA1 (0.61) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4961278 0.82 MAPT (0.60) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL14091298 0.82 ADORA1 (0.58) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4958725 0.81 ADORA1 (0.60) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4957609 0.81 ADORA1 (0.66) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4960364 0.81 MAPT (0.73) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4960548 0.79 ADORA1 (0.57) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4961540 0.78 KDM4E (0.59) MAPTKMT2AMEN1ALDH1A1BLM
SCHEMBL4957325 0.78 MAPT (0.71) MAPTKMT2AMEN1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US claimed
EP-1791822-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F.HOFFMANN-LA ROCHE AG (CH) 2007-06-06 EP claimed
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles HOFFMANN-LA ROCHE INC. 2006-02-09 US claimed
WO-2006013054-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 WO claimed
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US disclosed
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US disclosed
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US disclosed
EP-1791822-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F.HOFFMANN-LA ROCHE AG (CH) 2007-06-06 EP disclosed
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles HOFFMANN-LA ROCHE INC. 2006-02-09 US disclosed
WO-2006013054-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles SLC5A2, ABAT, AGTR2 MAPT 1360/4885KMT2A 1497/4885MEN1 4210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.